| 1 |
33503557 | Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. | 2021 Feb |
1 |
| 2 |
32537013 | Rosuvastatin protects against endothelial cell apoptosis in vitro and alleviates atherosclerosis in ApoE-/- mice by suppressing endoplasmic reticulum stress. | 2020 Jul |
1 |
| 3 |
33093907 | Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice. | 2020 Dec |
2 |
| 4 |
29162602 | Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering. | 2018 Jan |
4 |
| 5 |
30336263 | Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4Hα1 in ApoE-/- mice. | 2018 Dec |
1 |
| 6 |
26502925 | Combination of rosuvastatin and probucol inhibits MMP-9 expression via upregulation of miR-497 in cultured HUVECs and apoE knockout mice. | 2016 May |
3 |
| 7 |
26894432 | Heme Oxygenase-1 Expression Affects Murine Abdominal Aortic Aneurysm Progression. | 2016 |
1 |
| 8 |
27316397 | Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines. | 2016 Oct 15 |
1 |
| 9 |
25630951 | Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis. | 2015 Jun |
1 |
| 10 |
23276528 | Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. | 2013 Mar |
1 |
| 11 |
23509822 | In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin. | 2013 |
2 |
| 12 |
20015203 | Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment? | 2011 Feb |
1 |
| 13 |
22163030 | Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. | 2011 |
1 |
| 14 |
22169423 | [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice]. | 2011 Aug |
3 |
| 15 |
20554645 | The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. | 2010 Sep |
2 |
| 16 |
20946880 | Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD. | 2010 Nov 12 |
3 |
| 17 |
18162361 | Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. | 2009 Jan |
2 |
| 18 |
19111832 | Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice. | 2009 Jul |
1 |
| 19 |
18790840 | Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis. | 2008 Nov |
1 |
| 20 |
17350858 | Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. | 2007 May |
2 |
| 21 |
17433542 | Rosuvastatin reduces gliosis and the accelerated weight gain observed in WT and ApoE-/- mice exposed to a high cholesterol diet. | 2007 May 23 |
2 |
| 22 |
16005008 | Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. | 2006 Feb |
1 |
| 23 |
15454852 | Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis. | 2004 Oct |
1 |
| 24 |
12719275 | Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. | 2003 May 20 |
2 |